Redefining Metabolic Control in PKU: How Low Should We Go?

• Cary Harding, MD, FACMG - Oregon Health & Science University - Portland, OR
• Suzanne Hollander, MS, RD, LDN - Boston Children’s Hospital - Boston, MA
• Brittany Murray, MSN, FNP-BC - Boston Children’s Hospital – Boston, MA

While elevated phenylalanine (Phe) levels can have detrimental consequences on overall health and well-being, numerous factors make sustaining metabolic control in phenylketonuria (PKU) challenging. The symposium will feature an interactive panel discussion between experts sharing their valuable insights on:

• Understanding how therapeutic advancements influence blood Phe treatment targets in patients
• The evolution of the PKU diet and impact on patients at different ages
• The risks and benefits of aiming for normal Phe levels with unrestricted diet and the need for more evidence

Sponsored by:  BioMarin

*You must register for this session in advance as part of your conference registration. Registration is limited to metabolic dietitians in clinical practice or research.

Note: Breakfast will be available starting at 6:45 AM.